Walkiria Samuel Avila, Alexandre Jorge Gomes de Lucena, Claudia Maria Vilas Freire, Fabio Bruno da Silva, Ivan Romero Rivera, Juliana Rodrigues Soares Oliveira, Maria Alayde Mendonça Rivera, Regina Coeli de Carvalho, Vicente Avila Neto, Flávio Tarasoutchi
{"title":"REBECGA:巴西心脏病和妊娠登记处。妊娠期心脏病的多中心流行病学研究:回顾性队列。","authors":"Walkiria Samuel Avila, Alexandre Jorge Gomes de Lucena, Claudia Maria Vilas Freire, Fabio Bruno da Silva, Ivan Romero Rivera, Juliana Rodrigues Soares Oliveira, Maria Alayde Mendonça Rivera, Regina Coeli de Carvalho, Vicente Avila Neto, Flávio Tarasoutchi","doi":"10.36660/abc.20240807","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heart disease, which affects approximately 4% of pregnancies, is the leading non-obstetric cause of maternal death. It is estimated that 40% of these deaths could be prevented with a better understanding of pregnancy risks.</p><p><strong>Objectives: </strong>To develop the Brazilian Registry of Heart Diseases in Pregnancy (REBECGA) to study the prevalence, complications, and maternal mortality associated with heart diseases during pregnancy and postpartum.</p><p><strong>Methods: </strong>A multicenter retrospective study of pregnancy and postpartum follow up until 12 months after delivery in women with heart diseases, including analysis of predictive variables for maternal outcomes. A two-tailed significance level of 5% was adopted for statistical analysis.</p><p><strong>Results: </strong>A total of 638 pregnant women were included, with the following diagnoses: valvular disease (37.8%), congenital heart diseases (35.7%), arrhythmias without structural heart damage (14.7%), cardiomyopathies (11.3%), and other heart diseases (6.4%). The main complications were heart failure (16.7%), arrhythmia (10.7%), and syncope (8.0%), with 18 maternal deaths (2.8%), 10 of which occurred during the postpartum period. Cesarean delivery was indicated in 62.9% of cases, with 25.7% preterm births and 3.2% fetal losses. Multivariate analysis identified WHO class IV risk classification (OR 3.51; 95% CI 1.75-7.04; p < 0.001); NYHA class III/IV (OR 2.27; 95% CI 1.12-4.60; p = 0.023), and pulmonary hypertension (OR 2.45; 95% CI 1.05-5.70; p = 0.037) as predictive variables for maternal complications and deaths.</p><p><strong>Conclusions: </strong>REBECGA highlighted the prevalence of valvular disease, heart failure as the main complication, the postpartum period as a critical time for maternal deaths, and identified predictive risk variables for adverse pregnancy outcomes in women with heart disease.</p>","PeriodicalId":93887,"journal":{"name":"Arquivos brasileiros de cardiologia","volume":"122 8","pages":"e20240807"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"REBECGA: Brazilian Registry of Heart Disease and Pregnancy. Multicenter Epidemiological Study of Heart Diseases in Pregnancy: Retrospective Cohort.\",\"authors\":\"Walkiria Samuel Avila, Alexandre Jorge Gomes de Lucena, Claudia Maria Vilas Freire, Fabio Bruno da Silva, Ivan Romero Rivera, Juliana Rodrigues Soares Oliveira, Maria Alayde Mendonça Rivera, Regina Coeli de Carvalho, Vicente Avila Neto, Flávio Tarasoutchi\",\"doi\":\"10.36660/abc.20240807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Heart disease, which affects approximately 4% of pregnancies, is the leading non-obstetric cause of maternal death. It is estimated that 40% of these deaths could be prevented with a better understanding of pregnancy risks.</p><p><strong>Objectives: </strong>To develop the Brazilian Registry of Heart Diseases in Pregnancy (REBECGA) to study the prevalence, complications, and maternal mortality associated with heart diseases during pregnancy and postpartum.</p><p><strong>Methods: </strong>A multicenter retrospective study of pregnancy and postpartum follow up until 12 months after delivery in women with heart diseases, including analysis of predictive variables for maternal outcomes. A two-tailed significance level of 5% was adopted for statistical analysis.</p><p><strong>Results: </strong>A total of 638 pregnant women were included, with the following diagnoses: valvular disease (37.8%), congenital heart diseases (35.7%), arrhythmias without structural heart damage (14.7%), cardiomyopathies (11.3%), and other heart diseases (6.4%). The main complications were heart failure (16.7%), arrhythmia (10.7%), and syncope (8.0%), with 18 maternal deaths (2.8%), 10 of which occurred during the postpartum period. Cesarean delivery was indicated in 62.9% of cases, with 25.7% preterm births and 3.2% fetal losses. Multivariate analysis identified WHO class IV risk classification (OR 3.51; 95% CI 1.75-7.04; p < 0.001); NYHA class III/IV (OR 2.27; 95% CI 1.12-4.60; p = 0.023), and pulmonary hypertension (OR 2.45; 95% CI 1.05-5.70; p = 0.037) as predictive variables for maternal complications and deaths.</p><p><strong>Conclusions: </strong>REBECGA highlighted the prevalence of valvular disease, heart failure as the main complication, the postpartum period as a critical time for maternal deaths, and identified predictive risk variables for adverse pregnancy outcomes in women with heart disease.</p>\",\"PeriodicalId\":93887,\"journal\":{\"name\":\"Arquivos brasileiros de cardiologia\",\"volume\":\"122 8\",\"pages\":\"e20240807\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arquivos brasileiros de cardiologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36660/abc.20240807\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arquivos brasileiros de cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36660/abc.20240807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:心脏病影响约4%的妊娠,是孕产妇死亡的主要非产科原因。据估计,如果更好地了解怀孕风险,这些死亡中有40%是可以预防的。目的:建立巴西妊娠期心脏病登记处(REBECGA),研究妊娠期和产后与心脏病相关的患病率、并发症和孕产妇死亡率。方法:一项多中心回顾性研究,对患有心脏病的妇女进行妊娠和产后随访,直至分娩后12个月,包括对产妇结局的预测变量进行分析。采用双尾显著性水平5%进行统计学分析。结果:共纳入638例孕妇,诊断为:瓣膜病(37.8%)、先天性心脏病(35.7%)、无结构性心脏损害的心律失常(14.7%)、心肌病(11.3%)和其他心脏病(6.4%)。主要并发症为心力衰竭(16.7%)、心律失常(10.7%)和晕厥(8.0%),产妇死亡18例(2.8%),其中10例发生在产后。剖宫产占62.9%,早产占25.7%,胎儿丢失占3.2%。多因素分析确定WHO IV级风险分类(OR 3.51; 95% CI 1.75-7.04; p < 0.001);NYHA III/IV级(OR 2.27; 95% CI 1.12-4.60; p = 0.023)和肺动脉高压(OR 2.45; 95% CI 1.05-5.70; p = 0.037)是产妇并发症和死亡的预测变量。结论:REBECGA强调了心脏瓣膜疾病的患病率,心衰是主要并发症,产后是产妇死亡的关键时期,并确定了心脏病妇女不良妊娠结局的预测风险变量。
REBECGA: Brazilian Registry of Heart Disease and Pregnancy. Multicenter Epidemiological Study of Heart Diseases in Pregnancy: Retrospective Cohort.
Background: Heart disease, which affects approximately 4% of pregnancies, is the leading non-obstetric cause of maternal death. It is estimated that 40% of these deaths could be prevented with a better understanding of pregnancy risks.
Objectives: To develop the Brazilian Registry of Heart Diseases in Pregnancy (REBECGA) to study the prevalence, complications, and maternal mortality associated with heart diseases during pregnancy and postpartum.
Methods: A multicenter retrospective study of pregnancy and postpartum follow up until 12 months after delivery in women with heart diseases, including analysis of predictive variables for maternal outcomes. A two-tailed significance level of 5% was adopted for statistical analysis.
Results: A total of 638 pregnant women were included, with the following diagnoses: valvular disease (37.8%), congenital heart diseases (35.7%), arrhythmias without structural heart damage (14.7%), cardiomyopathies (11.3%), and other heart diseases (6.4%). The main complications were heart failure (16.7%), arrhythmia (10.7%), and syncope (8.0%), with 18 maternal deaths (2.8%), 10 of which occurred during the postpartum period. Cesarean delivery was indicated in 62.9% of cases, with 25.7% preterm births and 3.2% fetal losses. Multivariate analysis identified WHO class IV risk classification (OR 3.51; 95% CI 1.75-7.04; p < 0.001); NYHA class III/IV (OR 2.27; 95% CI 1.12-4.60; p = 0.023), and pulmonary hypertension (OR 2.45; 95% CI 1.05-5.70; p = 0.037) as predictive variables for maternal complications and deaths.
Conclusions: REBECGA highlighted the prevalence of valvular disease, heart failure as the main complication, the postpartum period as a critical time for maternal deaths, and identified predictive risk variables for adverse pregnancy outcomes in women with heart disease.